[42] Graeme Bell at Chiron Corporation led a team which isolated the two latter peptides, which are now known as glucagon-like peptide-1 and glucagon-like peptide-2
High cardiovascular risk: Patients with multiple risk factors (diabetes, hypertension, high cholesterol, smoking history, family history) likely benefit, though direct trial evidence in lower-risk populations is less extensive
Extended clinical trials and real-world data are crucial to understand their lasting impact on weight, metabolic health, and potential side effects
Dietitian Tip: You dont need large amounts of fat to reap the benefits
These are not over-the-counter supplements they require a doctors prescription and ongoing medical supervision
23096 La Paz, Baja California Sur